Udenyca Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Udenyca General Information

Description

Portfolio of a pharmaceutical drug designed to stimulate white blood cell production. The company offers a medication to help cancer patients recover from chemotherapy-induced neutropenia, enabling them to better tolerate treatment and reduce the risk of infection.

Contact Information

Website
www.udenyca.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Udenyca Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Udenyca‘s full profile, request access.

Request a free trial

Udenyca Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Udenyca‘s full profile, request access.

Request a free trial

Udenyca FAQs

  • Where is Udenyca headquartered?

    Udenyca is headquartered in .

  • What industry is Udenyca in?

    Udenyca’s primary industry is Buildings and Property.

  • Is Udenyca a private or public company?

    Udenyca is a Private company.

  • What is the current valuation of Udenyca?

    The current valuation of Udenyca is .

  • What is Udenyca’s current revenue?

    The current revenue for Udenyca is .

  • Who are Udenyca’s investors?

    Coherus Oncology has invested in Udenyca.

  • When was Udenyca acquired?

    Udenyca was acquired on 11-Apr-2025.

  • Who acquired Udenyca?

    Udenyca was acquired by Intas Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process